NIH-funded research R03 grant

Exploring how people with physical disabilities can fully participate in active eSports

Official title: Full participation of people with physical disabilities in active eSports

Funded at Cedars-Sinai Medical Center · NIH-10867470 · Data updated 2026-11-12

This study is looking at the challenges people with physical disabilities face when trying to join in on active eSports, so we can better understand their experiences and help make these fun activities more accessible for everyone.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJune 15, 2023
Project endDecember 31, 2025
Funding year2024
Award (this year)$83,500
NIH project number5R03HD111712-02
Project IDNIH-10867470 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 21 and older who have physical disabilities and are interested in participating in active eSports.

Less likely to help

Patients who do not have physical disabilities or are not interested in eSports may not benefit from this research.

What this research studies

This research investigates the barriers that individuals with physical disabilities face in participating in active eSports, a growing form of physical activity. It aims to identify the medical, psychological, social, and environmental challenges that hinder their involvement. By focusing on active eSports, the research seeks to promote physical activity among this population in a scalable and inclusive manner. The study will gather insights from participants to understand their experiences and needs better.

Why it matters

Potential benefit: If successful, this research could enhance the physical and mental well-being of individuals with disabilities by promoting greater participation in physical activities through eSports.

How similar studies have gone: While research on traditional sports participation for individuals with disabilities is established, the exploration of active eSports as a means of promoting physical activity is relatively novel.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Shirazipour, Celina Hove — Cedars-Sinai Medical Center
  • Study coordinator: Shirazipour, Celina Hove

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.